Clinical Trial Update: Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of tecovirimat in patients with monkeypox. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monkeypox

Drugs mentioned

• Tecovirimat (tecovirimat)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Monkeypox, Mpox | Phase 3 | Status: RECRUITING